Chemosensory dysfunction in Cushing's syndrome.


Journal

Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444

Informations de publication

Date de publication:
09 2021
Historique:
received: 05 02 2021
accepted: 23 03 2021
pubmed: 7 4 2021
medline: 21 9 2021
entrez: 6 4 2021
Statut: ppublish

Résumé

Cushing's syndrome (CS) can lead to structural changes in the brain and cognitive impairment, but chemosensory function has not been investigated yet. The aim was to analyze sense of smell and taste in patients with CS and explore the effect of therapy. The study cohort comprised 20 patients with florid CS treated between 2018 and 2020 in the outpatient clinic of the LMU Munich. We compared these 20 patients with CS to 40 healthy subjects matched for age, sex, and smoking status. Patients' sense of smell and taste was examined at diagnosis and 3 months after successful therapeutic surgery leading to clinical and biochemical remission. Odor threshold, discrimination, and identification were measured with "Sniffin' Sticks", taste was measured with "Taste Strips". Perceived sense of smell and taste was retrieved via a questionnaire. Patients with florid CS had significantly reduced smell (total smell score 30.3 vs. 34.4, p < 0.0005) and taste scores (9.5 vs. 12.0, p < 0.0005) compared to controls and significantly more frequently hyposmia (55 vs. 2.5%, p < 0.0005), hypogeusia (40 vs. 0%, p < 0.0005), and self-reported chemosensory impairment (60 vs. 0%, p < 0.0005). Three months after successful surgery, CS patients showed significant improvement of odor threshold (8.1 vs. 7.0, p < 0.0005), odor discrimination (12.0 vs. 11.0, p = 0.003), total smell score (33.4 vs. 30.3, p < 0.0005), and taste (11.5 vs. 9.5, p = 0.003). Chemosensory dysfunction is a novel and clinically relevant feature of CS.

Identifiants

pubmed: 33821391
doi: 10.1007/s12020-021-02707-z
pii: 10.1007/s12020-021-02707-z
pmc: PMC8325648
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

674-681

Informations de copyright

© 2021. The Author(s).

Références

Otolaryngol Clin North Am. 2004 Dec;37(6):1229-54
pubmed: 15563912
Biol Psychiatry. 1992 Nov 1;32(9):756-65
pubmed: 1450290
Chemosens Percept. 2014;7(2):91-101
pubmed: 24883171
Ther Clin Risk Manag. 2010 Oct 21;6:505-16
pubmed: 21063461
Am J Rhinol. 2007 Sep-Oct;21(5):570-3
pubmed: 17999792
Eur J Endocrinol. 2014 Oct;171(4):461-9
pubmed: 25005936
Chem Senses. 1997 Feb;22(1):39-52
pubmed: 9056084
J Alzheimers Dis. 2010;22(2):581-91
pubmed: 20847402
Eur Arch Otorhinolaryngol. 2005 Mar;262(3):231-5
pubmed: 15133691
Eur J Endocrinol. 2018 Aug;179(2):109-116
pubmed: 29875286
Eur Arch Otorhinolaryngol. 2000;257(4):205-11
pubmed: 10867835
J Neurol. 2009 Feb;256(2):242-8
pubmed: 19221845
Chem Senses. 2004 May;29(4):311-7
pubmed: 15150144
Arch Otolaryngol Head Neck Surg. 1991 May;117(5):519-28
pubmed: 2021470
Eur Arch Otorhinolaryngol. 2007 Mar;264(3):237-43
pubmed: 17021776
Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):157-162
pubmed: 32380562
Arq Neuropsiquiatr. 2010 Apr;68(2):252-7
pubmed: 20464295
Laryngoscope. 2007 Nov;117(11 Pt 2 Suppl 115):1-28
pubmed: 18075447
Eur Arch Otorhinolaryngol. 2020 Jun;277(6):1675-1680
pubmed: 32128609
Lancet Diabetes Endocrinol. 2016 Jul;4(7):569-76
pubmed: 27265184
Rhinology. 2017 Mar 1;55(1):17-26
pubmed: 28040824
Lancet Diabetes Endocrinol. 2016 Jul;4(7):611-29
pubmed: 27177728
Rhinology. 1996 Dec;34(4):222-6
pubmed: 9050101
Rhinology. 2003 Mar;41(1):2-6
pubmed: 12677732
Chem Senses. 2009 Oct;34(8):705-11
pubmed: 19759361
Eur J Endocrinol. 2013 Oct 21;169(6):811-9
pubmed: 24031092
Nervenarzt. 2008 Feb;79(2):175-84
pubmed: 17701389
Laryngorhinootologie. 2008 Sep;87(9):657-68; quiz 669-72
pubmed: 18726864
Am Fam Physician. 2000 Jan 15;61(2):427-36, 438
pubmed: 10670508
Chem Senses. 2016 Jul;41(6):479-86
pubmed: 27170667
Chin Med J (Engl). 2013 Aug;126(16):3156-60
pubmed: 23981629
Z Arztl Fortbild Qualitatssich. 2004 Jun;98(4):283-5
pubmed: 15295930
Lancet. 2015 Aug 29;386(9996):913-27
pubmed: 26004339
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc04
pubmed: 22558054
J Clin Neurosci. 2004 Nov;11(8):874-9
pubmed: 15519866
Ann Endocrinol (Paris). 2018 Jun;79(3):132-137
pubmed: 29625700

Auteurs

Elena Heger (E)

Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, München, Germany.

German Rubinstein (G)

Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, München, Germany.

Leah T Braun (LT)

Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, München, Germany.

Stephanie Zopp (S)

Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, München, Germany.

Jürgen Honegger (J)

Department of Neurosurgery, University of Tuebingen, Tübingen, Germany.

Max Seidensticker (M)

Klinik und Poliklinik für Radiologie, Ludwig-Maximilians-Universität, München, Germany.

Martin Reincke (M)

Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, München, Germany.

Andrea Oßwald (A)

Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, München, Germany. andrea.osswald@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH